EIF5A2 and non-small cell lung carcinoma: Additionally, overexpression of EIF5A2 is associated with poor prognosis in melanoma [22], nasopharyngeal carcinoma (NPC) [23], cervical cancer [24], and non-small-cell lung cancer (NSCLC) [25] patients.